Free Trial
NYSE:CNC

Centene (CNC) Stock Price, News & Analysis

Centene logo
$52.98 -0.59 (-1.09%)
Closing price 03:59 PM Eastern
Extended Trading
$52.90 -0.08 (-0.14%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Centene Stock (NYSE:CNC)

Advanced

Key Stats

Today's Range
$52.87
$54.75
50-Day Range
$31.72
$53.94
52-Week Range
$25.08
$64.15
Volume
5.03 million shs
Average Volume
6.67 million shs
Market Capitalization
$26.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$53.82
Consensus Rating
Hold

Company Overview

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 61% of companies evaluated by MarketBeat, and ranked 345th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.21, and is based on no strong buy ratings, 6 buy ratings, 11 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Centene is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Centene has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 25.14% in the coming year, from $3.46 to $4.33 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is -4.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is -4.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 1.03. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.81% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 2.89, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 0.70%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • News Sentiment

    Centene has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 53 news articles for Centene this week, compared to 11 articles on an average week.
  • Search Interest

    36 people have searched for CNC on MarketBeat in the last 30 days. This is an increase of 140% compared to the previous 30 days.
  • MarketBeat Follows

    14 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.37% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Stock News Headlines

Elon Musk’s $1 Quadrillion AI IPO
$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel
Centene (CNC) Gets a Hold from Mizuho Securities
Stock Movers: Alphabet, Clorox, Centene
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $41.18 at the start of the year. Since then, CNC shares have increased by 28.6% and is now trading at $52.9750.

Centene Corporation (NYSE:CNC) posted its quarterly earnings data on Tuesday, April, 28th. The company reported $3.37 earnings per share for the quarter, topping analysts' consensus estimates of $2.23 by $1.14. The business's revenue was up 7.1% compared to the same quarter last year.
Read the conference call transcript
.

Centene's stock split on Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were distributed to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

The following companies are subsidiaries of Centene: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and others.

Top institutional investors of Centene include Assenagon Asset Management S.A. (0.78%), Bank of New York Mellon Corp (0.51%), Focused Investors LLC (0.25%) and SG Americas Securities LLC (0.24%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Theodore R Samuels II, Christopher J Coughlin, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
4/28/2026
Today
5/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:CNC
CIK
1071739
Employees
61,100
Year Founded
1984

Price Target and Rating

High Price Target
$68.00
Low Price Target
$37.00
Potential Upside/Downside
+1.6%
Consensus Rating
Hold
Rating Score (0-4)
2.21
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
($13.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
15.31
P/E Growth
1.03
Net Income
-$6.67 billion
Net Margins
-3.25%
Pretax Margin
-3.22%
Return on Equity
5.57%
Return on Assets
1.54%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
1.12
Quick Ratio
1.12

Sales & Book Value

Annual Sales
$194.78 billion
Price / Sales
0.13
Cash Flow
$4.66 per share
Price / Cash Flow
11.38
Book Value
$40.76 per share
Price / Book
1.30

Miscellaneous

Outstanding Shares
493,800,000
Free Float
491,970,000
Market Cap
$26.16 billion
Optionable
Optionable
Beta
1.06

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:CNC) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners